241 related articles for article (PubMed ID: 11349742)
1. In vitro characteristics of tobramycin aerosol from ultrasonic and jet nebulizers.
Asmus MJ; Milavetz G; Tice AL; Teresi ME
Pharmacotherapy; 2001 May; 21(5):534-9. PubMed ID: 11349742
[TBL] [Abstract][Full Text] [Related]
2. Effect of nebulizer configuration on delivery of aerosolized tobramycin.
O'Riordan TG; Amram JC
J Aerosol Med; 1997; 10(1):13-23. PubMed ID: 10166359
[TBL] [Abstract][Full Text] [Related]
3. Physicochemical aspects and efficiency of albuterol nebulization: comparison of three aerosol types in an in vitro pediatric model.
Sidler-Moix AL; Di Paolo ER; Dolci U; Berger-Gryllaki M; Cotting J; Pannatier A
Respir Care; 2015 Jan; 60(1):38-46. PubMed ID: 25516995
[TBL] [Abstract][Full Text] [Related]
4. Effect of nebulizer type and antibiotic concentration on device performance.
Weber A; Morlin G; Cohen M; Williams-Warren J; Ramsey B; Smith A
Pediatr Pulmonol; 1997 Apr; 23(4):249-60. PubMed ID: 9141110
[TBL] [Abstract][Full Text] [Related]
5. In vitro aerodynamic characterization of the dose emitted during nebulization of tobramycin high strength solution by novel and jet nebulizer delivery systems.
Mashat M; Clark BJ; Assi KH; Chrystyn H
Pulm Pharmacol Ther; 2016 Apr; 37():37-42. PubMed ID: 26747025
[TBL] [Abstract][Full Text] [Related]
6. Inhalation of tobramycin in cystic fibrosis. Part 2: optimization of the tobramycin solution for a jet and an ultrasonic nebulizer.
Le Brun PP; de Boer AH; Gjaltema D; Hagedoorn P; Heijerman HG; Frijlink HW
Int J Pharm; 1999 Nov; 189(2):215-25. PubMed ID: 10536250
[TBL] [Abstract][Full Text] [Related]
7. The choice of jet nebulizer, nebulizing flow, and addition of albuterol affects the output of tobramycin aerosols.
Coates AL; MacNeish CF; Meisner D; Kelemen S; Thibert R; MacDonald J; Vadas E
Chest; 1997 May; 111(5):1206-12. PubMed ID: 9149571
[TBL] [Abstract][Full Text] [Related]
8. Inhalation of tobramycin in cystic fibrosis. Part 1: the choice of a nebulizer.
Le Brun PP; de Boer AH; Gjaltema D; Hagedoorn P; Heijerman HG; Frijlink HW
Int J Pharm; 1999 Nov; 189(2):205-14. PubMed ID: 10536249
[TBL] [Abstract][Full Text] [Related]
9. A comparison of the availability of tobramycin for inhalation from vented vs unvented nebulizers.
Coates AL; MacNeish CF; Lands LC; Meisner D; Kelemen S; Vadas EB
Chest; 1998 Apr; 113(4):951-6. PubMed ID: 9554630
[TBL] [Abstract][Full Text] [Related]
10. Albuterol delivery in an in vitro pediatric ventilator lung model: comparison of jet, ultrasonic, and mesh nebulizers.
Sidler-Moix AL; Dolci U; Berger-Gryllaki M; Pannatier A; Cotting J; Di Paolo ER
Pediatr Crit Care Med; 2013 Feb; 14(2):e98-102. PubMed ID: 23287904
[TBL] [Abstract][Full Text] [Related]
11. Aerosolization of Zn-DTPA Decorporation Agent Using Jet and Ultrasonic Nebulizers.
Mehri R; Tang W; Matida EA; Lai EPC
J Aerosol Med Pulm Drug Deliv; 2018 Oct; 31(5):311-320. PubMed ID: 29641361
[TBL] [Abstract][Full Text] [Related]
12. Design principles of liquid nebulization devices currently in use.
Rau JL
Respir Care; 2002 Nov; 47(11):1257-75; discussion 1275-8. PubMed ID: 12425742
[TBL] [Abstract][Full Text] [Related]
13. Fabrication, characterization and optimization of nanostructured lipid carrier formulations using Beclomethasone dipropionate for pulmonary drug delivery via medical nebulizers.
Khan I; Hussein S; Houacine C; Khan Sadozai S; Islam Y; Bnyan R; Elhissi A; Yousaf S
Int J Pharm; 2021 Apr; 598():120376. PubMed ID: 33617949
[TBL] [Abstract][Full Text] [Related]
14. Factors influencing the in vitro deposition of tobramycin aerosol: a comparison of an ultrasonic nebulizer and a high-frequency vibrating mesh nebulizer.
Pedersen KM; Handlos VN; Heslet L; Kristensen HG
J Aerosol Med; 2006; 19(2):175-83. PubMed ID: 16796542
[TBL] [Abstract][Full Text] [Related]
15. Effect of a Nebulizer Holding Chamber on Aerosol Delivery.
Sarhan RM; Elberry AA; Abdelwahab NS; Rabea H; Salem MN; Abdelrahim ME
Respir Care; 2018 Sep; 63(9):1125-1131. PubMed ID: 29789412
[TBL] [Abstract][Full Text] [Related]
16. Application of a droplet evaporation model to aerodynamic size measurement of drug aerosols generated by a vibrating mesh nebulizer.
Rao N; Kadrichu N; Ament B
J Aerosol Med Pulm Drug Deliv; 2010 Oct; 23(5):295-302. PubMed ID: 20455771
[TBL] [Abstract][Full Text] [Related]
17. Design characteristics for drug nebulizers.
Dennis JH; Hendrick DJ
J Med Eng Technol; 1992; 16(2):63-8. PubMed ID: 1404307
[TBL] [Abstract][Full Text] [Related]
18. In vitro comparison of five nebulizers during noninvasive ventilation: analysis of inhaled and lost doses.
Michotte JB; Jossen E; Roeseler J; Liistro G; Reychler G
J Aerosol Med Pulm Drug Deliv; 2014 Dec; 27(6):430-40. PubMed ID: 24517084
[TBL] [Abstract][Full Text] [Related]
19. Comparison of jet and ultrasonic nebulizer pulmonary aerosol deposition during mechanical ventilation.
Harvey CJ; O'Doherty MJ; Page CJ; Thomas SH; Nunan TO; Treacher DF
Eur Respir J; 1997 Apr; 10(4):905-9. PubMed ID: 9150333
[TBL] [Abstract][Full Text] [Related]
20. Delivery of glucocorticoids by jet nebulization: aerosol characteristics and output.
Leflein J; Brown E; Hill M; Kelly HW; Loffert DT; Nelson HS; Szefler SJ
J Allergy Clin Immunol; 1995 May; 95(5 Pt 1):944-9. PubMed ID: 7751514
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
